Tumor News and Research

RSS

Researchers develop new approach to treating cancer using enzyme therapy

Researchers at The University of Texas at Austin have developed a new approach to treating cancer using enzyme therapy.

29 Aug 2018

New approach to assess kidney tumors could prevent patients from undergoing unnecessary surgery

A research team from Roswell Park Comprehensive Cancer Center has discovered a way to use computed tomography imaging to assess kidney tumors that test positive for the biomarker CD117 and accurately determine before surgery, whether the tumor is benign or malignant.

29 Aug 2018

Researchers find how NF2 gene mutations lead to out-of-control cellular proliferation

A team of Massachusetts General Hospital Cancer Center researchers has determined one way that mutations in a gene involved in a rare, hereditary cancer syndrome lead to out-of-control cellular proliferation.

29 Aug 2018

Researchers identify neutrophil progenitor in the bone marrow of mice and humans

Neutrophils-;short-lived, highly mobile and versatile-;outnumber all other immune cells circulating through the blood stream.

29 Aug 2018

New technique for mapping flow of biomolecules in tumor microenvironment

Cancer researchers struggle to identify tumor cells that are interspersed within nonmalignant tissues because tumor cells exploit the tissue environment and monopolize available resources to continue growing.

29 Aug 2018

Researchers enlist genes that control production of cellular energy stored in ATP molecules

Everything the body does--your brain thinking, your heart beating, your cells growing--requires energy. Consequently, it comes as no surprise that disruptions in energy production can contribute to a wide range of diseases.

29 Aug 2018

A non-canonical approach may improve radiation treatment for cancer

Although the success or failure of radiation therapy for cancer has long been associated with the intrinsic radio-resistance or radio-sensitivity of tumor cells, a new approach is demonstrating that radiation can take credit for an additional benefit -; causing highly effective secondary immune responses that can enhance anti-tumor immunity.

28 Aug 2018

Using clinical quality registers to compare institutions or physicians may be misleading

Many clinical quality registries have been established during the 2000s, particularly in North America where such registers are used as a criterion for health care funding.

28 Aug 2018

Researchers develop new way to detect cancer cells in the blood using malaria protein

Cancer tumor cells in the blood can be more accurately and cheaply detected using a malaria protein, new research led by UNSW’s Chris Heeschen shows.

28 Aug 2018

New combination treatment could help some people with advanced melanoma

A UCLA-led study has found that a treatment that uses a bacteria-like agent in combination with an immunotherapy drug could help some people with advanced melanoma, an aggressive form of skin cancer, live longer.

28 Aug 2018

Researchers launch clinical trial to assess new drug combination against metastatic breast cancers

Researchers at University of California San Diego School of Medicine have launched a phase Ib clinical trial to assess the safety and tolerability of cirmtuzumab, in combination with standard chemotherapy, to treat metastatic or locally advanced breast cancer that cannot be surgically removed.

28 Aug 2018

Researchers reveal an unlikely protector against growth of metastatic breast cancer

At the time of initial diagnosis, most patients with breast cancer show no signs that their cancer has spread elsewhere in the body. Yet, up to 30 percent of patients will ultimately experience metastasis, with breast cancer taking root and growing at other sites in the body, sometimes months, years or even decades later.

27 Aug 2018

Additional inhibitor could be key to helping anti-VEGF therapies overcome resistance in glioblastoma

Adding another inhibitor to therapies that cut off a tumor's access to blood vessels could be the key to helping those therapies overcome resistance in glioblastoma, a deadly form of brain cancer.

27 Aug 2018

New personalized cellular therapy approved for use in the European Union

The European Commission has approved a personalized cellular therapy developed at the University of Pennsylvania's Abramson Cancer Center, making it the first chimeric antigen receptor (CAR) T cell therapy permitted for use in the European Union in two distinct indications.

27 Aug 2018

Tumor News and Research

Researchers develop new approach to treating cancer using enzyme therapy

New approach to assess kidney tumors could prevent patients from undergoing unnecessary surgery

Researchers find how NF2 gene mutations lead to out-of-control cellular proliferation

Researchers identify neutrophil progenitor in the bone marrow of mice and humans

New technique for mapping flow of biomolecules in tumor microenvironment

Researchers enlist genes that control production of cellular energy stored in ATP molecules

A non-canonical approach may improve radiation treatment for cancer

Using clinical quality registers to compare institutions or physicians may be misleading

Researchers develop new way to detect cancer cells in the blood using malaria protein

New combination treatment could help some people with advanced melanoma

Researchers launch clinical trial to assess new drug combination against metastatic breast cancers

Researchers reveal an unlikely protector against growth of metastatic breast cancer

Additional inhibitor could be key to helping anti-VEGF therapies overcome resistance in glioblastoma

New personalized cellular therapy approved for use in the European Union

Discovery will allow scientists to target hypoxia in cancer

Some breast cancers can prevent their own spread

New radiomic signature offers predictive score for efficacy of immunotherapy in patients

Death of Sen. John McCain sheds new light on aggressive brain tumor

Mccain’s complicated health care legacy: He hated the ACA. He also saved it.

Forbius receives $18.75 million grant from CPRIT for Phase 2a development of AVID100

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News